Tanger Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on events occurring on May 9, 2025, specifically the 2025 Annual Meeting of Shareholders and a subsequent Board of Directors action regarding share repurchases. The registrants are Tanger Inc. and Tanger Properties Limited Partnership.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance outcomes and capital allocation authorization.
Material Changes and Corporate Actions
- Share Repurchase Authorization: The Board authorized a new share repurchase program for up to $200 million of outstanding common shares. This replaces the prior authorization of approximately $100 million, which was set to expire on May 31, 2025.
- Annual Meeting Results:
- Director Elections: All nine nominees were elected. Votes against ranged from approximately 110,000 to 2.5 million per nominee, with Jeffrey B. Citrin and Thomas J. Reddin receiving the highest number of "against" votes.
- Auditor Ratification: Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Executive Compensation: Shareholders approved, on an advisory basis, the compensation of named executive officers.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of specific risks or contingencies beyond the standard disclosure that the share repurchase plan may be modified, suspended, or discontinued at any time and is subject to applicable federal securities laws.
Investor Verification Checklist
- Verify the total number of shares outstanding to assess the potential impact of the new $200 million repurchase authorization.
- Review the specific terms of the Rule 10b5-1 plans if the company elects to use them for future repurchases.
- Monitor future filings for the actual execution of share repurchases under the new authorization.
- Confirm the tenure of the newly elected directors and any changes to committee assignments.